China, Nov. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A study on the prediction of the efficacy of novel endocrine therapy for prostate cancer bone metastasis using multimodal image-based models'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136727

Registration Time: 2026/11/14

Type: Observational study

Primary Sponsor: The Second Affiliated hospital of Fujian Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=353431

Published by HT Digital Content Services with permission from Health Daily Digest....